CEDM, MBI outperform MRI for breast cancer staging
Contrast-enhanced digital mammography (CEDM) and molecular breast imaging (MBI)...Read more on AuntMinnie.comRelated Reading: Image processing shows potential to reduce MBI dose MBI useful in particular breast screening scenarios CEDM a useful alternative for breast cancer screening Tissue enhancement affects breast MRI interpretation Preop breast MRI forecasts positive tumor margins
The Research Letter titled “Evaluation of Triple-Negative Breast Cancer Early Detection Via Mammography Screening and Outcomes in African American and White American Patients,” published online February 19, 2020, included an error in the Methods section and another in the Results section. The Methods section notes the dat e of study termination as April 30, 2018. In fact, it was September 14, 2018. The Results section notes a median (range) follow-up time as 50.3 (1-36) months for African American patients; this should have been reported as 50.3 (1-91) months. Both errors have been corrected online.
ConclusionsAccordingly, data mining approaches are proved to be a helpful tool to make the final decision as to whether patients should be referred to biopsy or not based on mammography reports. The developed CDSS may also be helpful especially for less experienced radiologists.
Condition: Breast Cancer Interventions: Diagnostic Test: Serum Autotaxin; Radiation: chest x-ray; Diagnostic Test: Breast ultrasound or mammography; Diagnostic Test: Histopathological examination of breast mass specimens; Radiation: Magnetic Resonance Imaging ( MRI) and Bone scan; Diagnostic Test: Peripheral haemogram; Diagnostic Test: Renal and liver functions; Diagnostic Test: Prothrombin time and concentration; Diagnostic Test: Cancer Antigen...
Research reveals half of radiologists saw no change in their recall rates.
ConclusionsBoth CESM and MRI are effective methods for the detection of breast cancer with high diagnostic sensitivity. The diagnostic performance of CESM appears to be more effective than MRI.
Dr. Laura Mulvey, 33, practices emergency medicine at Maimonides Medical Center in Brooklyn, New York. After spending six days receiving treatment in her own hospital, she is now recovering at home from what is presumed to be COVID-19, though her test was inconclusive. What follows is a lightly-edited transcript of her story as told to TIME. Early on, sometime in February, [COVID-19] was something that people were thinking about. And worried about. Certainly, the worries were not what they are now. But hospital-wise, we had a bit of an earlier jump on it, because we recognized that this was a potential threat. We’re ...
(JAMA Network) Nearly 200 radiologists who interpreted about 251,000 digital breast tomosynthesis (DBT) and 2 million digital mammography screening examinations were included in this observational study that evaluated recall and cancer detection rates.
AbstractPurpose of ReviewTo bring the reader up to date on recent literature on cancer detection with digital breast tomosynthesis (DBT).Recent FindingsMany early landmark trials have recently published follow-up studies comparing DBT and synthesized DBT (SM + DBT) to digital mammography (DM). Recent work has also focused on interval cancers and biological characteristics of DBT cancers in efforts to assess the impact of cancer detection with DBT.SummaryConsistent increases in cancer detection and overall reductions in recall rates are observed with DBT and maintained with SM + DBT. Studies on...
Publication date: Available online 27 March 2020Source: Journal of the American College of RadiologyAuthor(s): Claire C. Conley, Bethany L. Niell, Bianca M. Augusto, McKenzie McIntyre, Richard Roetzheim, Kimberly Funaro, Susan T. Vadaparampil
Shortened protocol identifies more cancers than ultrasound or mammography.